Go to content
UR Home

Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals

URN to cite this document:
DOI to cite this document:
Mader, Anna-Lena ; Tydykov, Leonid ; Glück, Vivian ; Bertok, Manuela ; Weidlich, Tanja ; Gottwald, Christine ; Stefl, Alexa ; Vogel, Matthias ; Plentz, Annelie ; Köstler, Josef ; Salzberger, Bernd ; Wenzel, Jürgen J. ; Niller, Hans Helmut ; Jantsch, Jonathan ; Wagner, Ralf ; Schmidt, Barbara ; Glück, Thomas ; Gessner, André ; Peterhoff, David
Date of publication of this fulltext: 16 Aug 2022 14:17


SARS-CoV-2 Omicron is the first pandemic variant of concern exhibiting an abrupt accumulation of mutations particularly in the receptor-binding domain that is a critical target of vaccination induced and therapeutic antibodies. Omicron's mutations did only marginally affect the binding of ACE2, and the two antibodies Sotrovimab and CR3022 but strongly impaired the binding of Casirivimab and ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons